Selank

Selank is a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin, studied in non-human models in relation to GABAergic signaling, neurotrophic factor expression (including BDNF), and immune peptide pathway behavior. Scientific literature examines this compound in the context of anxiolytic-associated signaling, cognitive function research models, and cytokine regulation in non-human research environments.

Research applications commonly explored in the literature include:

GABAergic and anxiolytic-associated signaling pathway investigation in non-human models

BDNF and neurotrophic factor expression research in neurological research frameworks

Immune peptide regulation and cytokine signaling studies

Tuftsin-analogue comparative activity and receptor interaction research

Neuropeptide stability and metabolic resistance modeling in controlled laboratory settings

The lyophilized vial format allows researchers to evaluate compound stability, reconstitution characteristics, and handling parameters within controlled laboratory settings, supporting consistency across experimental preparation. Each Selank 5 mg vial from KÖLD is prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity.

1. What is Selank studied for in research settings?
Selank appears in scientific literature in relation to GABAergic signaling pathways, BDNF expression, and immune peptide regulation. Research models investigate its behavior within anxiolytic-associated signaling frameworks and neuroregulatory pathway studies in non-human systems.

2. What is the structural classification of Selank?
Selank is a synthetic heptapeptide — a seven amino acid sequence — developed as a stabilized analogue of tuftsin, an endogenous tetrapeptide associated with immune signaling. Its structural modification is studied for its effect on metabolic stability compared to its parent compound.

3. How does Selank relate to tuftsin in research literature?
Tuftsin is an endogenous immunopeptide; Selank was developed as a synthetic analogue with extended metabolic stability. Scientific literature examines how structural modification of the tuftsin sequence influences receptor binding behavior, signaling outcomes, and compound half-life in non-human research systems.

4. Is Selank approved for any use in humans or animals?
No. Selank is not approved for human or veterinary use in the jurisdictions in which KÖLD operates. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.

5. How is purity and quality verified?
Each Selank 5 mg vial undergoes independent third-party laboratory testing to confirm molecular identity, purity, and volume accuracy prior to release.

Before Reconstitution

Store sealed vial in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.